27 May - General Information Only
ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) skyrocketed 11.46%, extending gains after news that its experimental blood thinner was more effective than an approved drug in patients undergoing total knee replacement surgery. The company said patients treated with a 300 mg dose of the drug, ISIS-FXIRx, experienced a significantly lower incidence of blood clots in their veins, compared to patients given the approved drug, enoxaparin. The trial was evaluating 200 mg and 300 mg doses of the treatment against enoxaparin in 300 patients in a mid-stage study. The 200 mg dose did not show any significant benefit over enoxaparin.
- Forums
- ASX - By Stock
- PER
- more antisense technology advances
more antisense technology advances
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.5¢ |
Change
0.005(5.00%) |
Mkt cap ! $94.66M |
Open | High | Low | Value | Volume |
10.5¢ | 10.5¢ | 10.0¢ | $10.98K | 106.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 921845 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 284463 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 921845 | 0.100 |
5 | 283191 | 0.099 |
3 | 408491 | 0.098 |
3 | 131927 | 0.097 |
2 | 25004 | 0.096 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 284463 | 3 |
0.110 | 294063 | 6 |
0.115 | 763850 | 6 |
0.120 | 354642 | 9 |
0.125 | 110429 | 2 |
Last trade - 11.51am 10/10/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
EL8
ELEVATE URANIUM LTD
Murray Hill, MD & CEO
Murray Hill
MD & CEO
SPONSORED BY The Market Online